Blood–brain barrier dysfunction in the pathogenesis of major depressive disorder
S Wu, Y Yin, L Du - Cellular and Molecular Neurobiology, 2022 - Springer
Major depression represents a complex and prevalent psychological disease that is
characterized by persistent depressed mood, impaired cognitive function and complicated …
characterized by persistent depressed mood, impaired cognitive function and complicated …
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: a systematic review and meta-analysis
Y Shi, D Luan, R Song, Z Zhang - European Neuropsychopharmacology, 2020 - Elsevier
The neurotrophin hypothesis indicates that neurotrophic factors are important for the
pathophysiology of major depressive disorder (MDD), with alterations in peripheral …
pathophysiology of major depressive disorder (MDD), with alterations in peripheral …
Biomarkers and detection methods of bipolar disorder
X Hu, C Yu, T Dong, Z Yang, Y Fang, Z Jiang - Biosensors and …, 2023 - Elsevier
Bipolar disorder is one of the severe mental diseases. Its high misdiagnosis rate and long-
time delayed diagnosis are related to the fact that the diagnosis procedure is mainly …
time delayed diagnosis are related to the fact that the diagnosis procedure is mainly …
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical …
Although results are still preliminary, ketamine and classical hallucinogens have shown
promise in recent years as novel, fast-acting antidepressants, especially for the treatment of …
promise in recent years as novel, fast-acting antidepressants, especially for the treatment of …
Hippocampal volume change following ECT is mediated by rs699947 in the promotor region of VEGF
MJA Van Den Bossche, L Emsell, A Dols… - Translational …, 2019 - nature.com
Several studies have shown that electroconvulsive therapy (ECT) results in increased
hippocampal volume. It is likely that a multitude of mechanisms including neurogenesis …
hippocampal volume. It is likely that a multitude of mechanisms including neurogenesis …
Change of circulating vascular endothelial growth factor level and reduction of anhedonia are associated in patients with major depressive disorder treated with …
M Elemery, S Kiss, P Dome, L Pogany, G Faludi… - Frontiers in …, 2022 - frontiersin.org
Aim Vascular endothelial growth factor (VEGF) has been implicated in mediating the effect of
antidepressant therapies as it plays a significant role in the neurogenesis. Anhedonia, an …
antidepressant therapies as it plays a significant role in the neurogenesis. Anhedonia, an …
Clinical improvement in depression and cognitive deficit following electroconvulsive therapy
AM Ahmad Hariza, MH Mohd Yunus, JK Murthy… - Diagnostics, 2023 - mdpi.com
Electroconvulsive therapy (ECT) is a long-standing treatment choice for disorders such as
depression when pharmacological treatments have failed. However, a major drawback of …
depression when pharmacological treatments have failed. However, a major drawback of …
Depression, GABA, and age correlate with plasma levels of inflammatory markers
Immunomodulation is increasingly being recognised as a part of mental diseases. Here, we
examined whether levels of immunological protein markers changed with depression, age …
examined whether levels of immunological protein markers changed with depression, age …
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive …
L Kranaster, K Blennow, H Zetterberg… - Journal of affective …, 2019 - Elsevier
Background Several lines of evidence are pointing towards an involvement of the vascular
endothelial growth factor (VEGF) in the pathophysiology of depression. There are studies …
endothelial growth factor (VEGF) in the pathophysiology of depression. There are studies …
In vivo evidence of increased vascular endothelial growth factor in patients with major depressive disorder
Background Vascular endothelial growth factor (VEGF) is a candidate mediator of blood-
brain barrier (BBB) disruption in depression. However, previous studies have mainly …
brain barrier (BBB) disruption in depression. However, previous studies have mainly …